RESUMEN
OBJECTIVES: The aim of this study was to investigate racial and socioeconomic disparities for patients with pancreatic cancer across different facility types. METHODS: The National Cancer Database was queried for pancreatic cancer cases from 2004 to 2015. Along with propensity score matching analysis, multivariate logistic and Cox model were used to assess effects of facility type, race, elements of socioeconomics on receipt of treatment, time to treatment, and overall survival, separately. RESULTS: Among 223,465 patients, 44.6%, 42.1%, and 13.3% were treated at academic, community, and integrated facilities, respectively. Private insurance was associated with more treatment (odds ratio, 1.41; P < 0.001) and better survival [hazards ratio (HR), 0.84; P < 0.001]. Higher education was associated with earlier treatment (HR, 1.09; P < 0.001). African Americans had less treatment (odds ratio, 0.97; P = 0.04) and delayed treatment (HR, 0.89; P < 0.001) despite later stage at diagnosis. After adjusting for socioeconomic status, African Americans had similar survival (HR, 0.99; P = 0.11) overall and improved survival (HR, 0.95; P = 0.016) at integrated facilities. CONCLUSIONS: Higher socioeconomic status was associated with better treatment and survival. After adjusting for socioeconomic disparities, race did not affect survival. Less racial disparity was observed at integrated facilities.
Asunto(s)
Adenocarcinoma , Negro o Afroamericano , Instituciones de Salud , Disparidades en el Estado de Salud , Disparidades en Atención de Salud/etnología , Evaluación de Procesos y Resultados en Atención de Salud , Neoplasias Pancreáticas , Clase Social , Determinantes Sociales de la Salud/etnología , Población Blanca , Centros Médicos Académicos , Adenocarcinoma/etnología , Adenocarcinoma/mortalidad , Adenocarcinoma/terapia , Anciano , Instituciones Oncológicas , Bases de Datos Factuales , Prestación Integrada de Atención de Salud , Femenino , Humanos , Seguro de Salud , Masculino , Persona de Mediana Edad , Neoplasias Pancreáticas/etnología , Neoplasias Pancreáticas/mortalidad , Neoplasias Pancreáticas/terapia , Factores Raciales , Estudios Retrospectivos , Medición de Riesgo , Factores de Riesgo , Resultado del Tratamiento , Estados Unidos/epidemiologíaRESUMEN
Importance: New-onset diabetes after the age of 50 years is a potential indicator of pancreatic cancer. Understanding the associations between hyperglycemia, diabetes, and pancreatic cancer, including pancreatic ductal adenocarcinoma, is key to developing an approach to early detection. Objective: To assess the association of elevation in glycated hemoglobin (HbA1c) with the risk of pancreatic cancer. Design, Setting, and Participants: This cohort study was conducted using data collected from an integrated health care system in California. A total of 851â¯402 patients aged 50 to 84 years who had HbA1c measurements taken between 2010 and 2014 were identified as the base cohort, with 12 contemporaneous cohorts created based on varying HbA1c thresholds (ie, 6.1%, 6.3%, 6.5%, and 6.7%) and prior diabetes status. Data analysis was conducted from August 2018 to September 2019. Main Outcomes and Measures: New cases of pancreatic cancer identified through cancer registry and California death files during a 3-year period. Three-year risk, incidence rate, sensitivity, number of patients needed to screen to detect 1 case, timing, and stage at diagnosis were determined. Results: Among 851â¯402 patients in the base cohort, 447â¯502 (52.5%) were women, 255â¯441 (30.0%) were Hispanic participants, 383â¯685 (45.1%) were non-Hispanic white participants, 100â¯477 (11.8%) were Asian participants, and 88â¯969 (10.4%) were non-Hispanic black participants, with a median (interquartile range) age of 62 (56-69) years and a median (interquartile range) HbA1c level of 6.0% (5.7%-6.6%). The incidence rate of pancreatic cancer was 0.45 (95% CI, 0.43-0.49) per 1000 person-years. After excluding prior diabetes as well as confirmation of new-onset hyperglycemia based on an HbA1c level of 6.5%, a total of 20â¯012 patients remained, with 74 of 1041 pancreatic ductal adenocarcinoma cases (7.1%) from the base cohort included. The rate of pancreatic cancer was 0.72 (95% CI, 0.32-1.42) per 1000 person-years among Asian patients, 0.83 (95% CI, 0.35-1.71) per 1000 person-years among non-Hispanic black patients, 0.84 (95% CI, 0.48-1.37) per 1000 person-years among Hispanic patients, and 2.37 (95% CI, 1.75-3.14) per 1000 person-years among non-Hispanic white patients. Overall, 42 of 74 cancers (56.8%) were diagnosed within 1 year of the index laboratory test. Among 1041 total cases, 708 (68.0%) had staging information available, of whom 465 (65.7%) had stage III or IV disease at diagnosis. In the base cohort, the number needed to undergo evaluation to identify a single case of pancreatic ductal adenocarcinoma was 818 (95% CI, 770-869), with estimates ranging from 206 (95% CI, 160-264) to 600 (95% CI, 540-666) in the subcohorts. Conclusions and Relevance: The findings of this study suggest that screening patients for pancreatic cancer based solely on elevation in HbA1c level is unlikely to represent an effective strategy. Future efforts to identify a high-risk population based on changes in glycemic parameters should account for racial/ethnic differences.
Asunto(s)
Carcinoma Ductal Pancreático/epidemiología , Diabetes Mellitus/sangre , Hemoglobina Glucada/metabolismo , Neoplasias Pancreáticas/epidemiología , Negro o Afroamericano/estadística & datos numéricos , Anciano , Anciano de 80 o más Años , Asiático/estadística & datos numéricos , California/epidemiología , Carcinoma Ductal Pancreático/etnología , Carcinoma Ductal Pancreático/patología , Diabetes Mellitus/diagnóstico , Femenino , Hispánicos o Latinos/estadística & datos numéricos , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Estadificación de Neoplasias , Neoplasias Pancreáticas/etnología , Neoplasias Pancreáticas/patología , Estudios Retrospectivos , Factores de Riesgo , Factores de Tiempo , Población Blanca/estadística & datos numéricosRESUMEN
OBJECTIVES: African Americans (AAs) have disproportionately higher incidence and lower survival rates from pancreatic cancer compared with whites. Historically, this disparity has been attributed to modifiable risk factors. Recent studies suggest that nonmodifiable aspects may also play an important role. We review these new contributions as potential targets for closing the disparity. METHODS: A PubMed search was conducted to review studies of nonmodifiable elements contributing to pancreatic cancer disparities in AAs. RESULTS: Several nonmodifiable risks are associated with the racial disparity in pancreatic cancer. SSTR5 P335L, Kaiso, and KDM4/JMJD2A demonstrate differential racial expression, increasing their potential as therapeutic targets. Many social determinants of health and their associations with diabetes, obesity, and the microbiome are partially modifiable risk factors that significantly contribute to outcomes in minorities. Barriers to progress include the low minority inclusion in research studies. CONCLUSIONS: Genomics, epigenetics, the microbiome, and social determinants of health are components that contribute to the pancreatic cancer disparity in AAs. These factors can be researched, targeted, and modified to improve mortality rates. Closing the disparity in pancreatic cancer will require an integrated approach of personalized medicine, increased minority recruitment to studies, and advanced health care/education access.
Asunto(s)
Neoplasias Pancreáticas/terapia , Negro o Afroamericano/genética , Negro o Afroamericano/estadística & datos numéricos , Disparidades en el Estado de Salud , Disparidades en Atención de Salud , Historia Antigua , Humanos , Neoplasias Pancreáticas/etnología , Neoplasias Pancreáticas/genética , Factores de Riesgo , Estados Unidos , Población Blanca/genética , Población Blanca/estadística & datos numéricosRESUMEN
OBJECTIVES: The objective of this study was to evaluate whether disparities in pancreatic cancer diagnosis, treatment, and survival are reduced in an integrated health system. METHODS: We conducted a retrospective study (2006-2014) among patients with pancreatic cancer from Kaiser Permanente Southern California. Racial ethnic groups included non-Hispanic whites (NHW), non-Hispanic blacks (NHB), Hispanics, and Asians. We used multivariable and Cox regression analyses to evaluate disparities in diagnosis and treatment utilization (oncology care, surgery, time to surgery, chemotherapy) and overall survival, respectively. RESULTS: Among 2103 patients, 54% were diagnosed with stage IV disease, 80% received oncology consultation, 20% received surgery with mean time to surgery 27 days (standard deviation, 36.8), 50.4% received chemotherapy. Mean overall survival was 8.6 months (standard deviation, 11.5). There were no differences in odds of stage IV diagnosis, oncology consultation, surgery, or time to surgery by racial ethnic group. Asians were more likely to receive chemotherapy (odds ratio, 1.59; 95% confidence interval [CI], 1.09-2.32) compared to NHW. NHB (hazard ratio, 0.78; 95% CI, 0.67-0.91) and Asians (hazard ratio, 0.81; 95% CI, 0.66-1.00) had improved survival compared to NHW. CONCLUSIONS: Minorities were not disadvantaged in pancreatic cancer care. Improved health care coordination may improve current disparities.
Asunto(s)
Atención a la Salud/estadística & datos numéricos , Disparidades en el Estado de Salud , Neoplasias Pancreáticas/diagnóstico , Neoplasias Pancreáticas/terapia , Negro o Afroamericano/estadística & datos numéricos , Anciano , Anciano de 80 o más Años , Pueblo Asiatico/estadística & datos numéricos , California , Femenino , Hispánicos o Latinos/estadística & datos numéricos , Humanos , Masculino , Persona de Mediana Edad , Neoplasias Pancreáticas/etnología , Modelos de Riesgos Proporcionales , Estudios Retrospectivos , Población Blanca/estadística & datos numéricosRESUMEN
BACKGROUND: Most previous prospective studies in Western countries found no association between consumption of fish and n-3 (ω-3) polyunsaturated fatty acids (PUFAs), such as eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA), for which the main source is fish, and pancreatic cancer risk. However, prospective evidence is still lacking among populations who have a relatively higher fish consumption. OBJECTIVE: We investigated the association between fish and n-3 PUFA consumption and pancreatic cancer risk in a population-based, prospective study in Japanese men and women. DESIGN: The Japan Public Health Center-based Prospective Study (JPHC study) has enrolled 140,420 subjects. We analyzed data on 82,024 eligible participants aged 45-74 y without a history of cancer who responded to a validated food-frequency questionnaire that included 138 items in 1995 for cohort I and in 1998 for cohort II. Participants were followed through 2010. HRs and corresponding 95% CIs for the highest compared with lowest quartile were calculated by using multivariable-adjusted Cox proportional hazards regression models. RESULTS: During 1,068,774 person-years of follow-up, 449 newly diagnosed pancreatic cancers were identified. After the exclusion of pancreatic cancer cases in the first 3 y of follow-up, we found an inverse association of marine n-3 PUFA (EPA+DPA+DHA) and DHA consumption with pancreatic cancer risk: compared with the lowest quartile, multivariate-adjusted HRs in the highest quartile were 0.70 (95% CI: 0.51, 0.95; P-trend = 0.07) and 0.69 (0.51, 0.94; P-trend = 0.03), respectively. Associations for total fish, n-3 PUFA, EPA, and DPA consumption were similar but were not significant. CONCLUSION: High n-3 PUFA, especially marine n-3 PUFAs, and DHA consumption was associated with a lower risk of pancreatic cancer in a population with a large variation in fish consumption, although the data apply to only a portion of the JPHC study subjects.
Asunto(s)
Dieta , Ácidos Grasos Omega-3/uso terapéutico , Peces , Neoplasias Pancreáticas/prevención & control , Alimentos Marinos , Adulto , Anciano , Animales , Estudios de Cohortes , Dieta/etnología , Ácidos Docosahexaenoicos/administración & dosificación , Ácidos Docosahexaenoicos/uso terapéutico , Ácidos Grasos Omega-3/administración & dosificación , Femenino , Estudios de Seguimiento , Humanos , Incidencia , Japón/epidemiología , Masculino , Persona de Mediana Edad , Encuestas Nutricionales , Neoplasias Pancreáticas/epidemiología , Neoplasias Pancreáticas/etnología , Modelos de Riesgos Proporcionales , Estudios Prospectivos , Sistema de Registros , Riesgo , Alimentos Marinos/análisisRESUMEN
PURPOSE: The main purpose of this study was to determine the prevalence of pathogenic BRCA1 and BRCA2 mutations in a consecutively ascertained clinic-based cohort of patients with pancreatic ductal adenocarcinoma and describe the clinical and family history characteristics. PATIENTS AND METHODS: Unselected, consecutive, incident patients with pancreatic ductal adenocarcinoma were recruited at a single cancer center over a 2-year period. Participants provided blood for DNA analysis and cancer family history, and cancer treatment records were reviewed. DNA from all patients was analyzed by Sanger sequencing and multiplex ligation-dependent probe amplification for germline variants in BRCA1 and BRCA2. RESULTS: Three hundred six patients were eligible for analysis. Pathogenic germline BRCA mutations were identified in 14 patients (4.6%; 95% CI, 2.2% to 6.9%), including 11 patients with a BRCA2 mutation and three patients with a BRCA1 mutation. Having a cancer family history that met genetic testing criteria of the National Comprehensive Cancer Network or the Ontario Ministry of Health and Long-Term Care or self-reporting as Ashkenazi Jewish was significantly associated with BRCA mutation carrier status (P=.02, P<.001, and P=.05, respectively). However, the majority of the BRCA mutation-positive patients did not actually meet these genetic testing criteria. CONCLUSION: Pathogenic BRCA mutations were identified in 4.6% of a large cohort of clinic-based patients. Considering the implications for family members of BRCA carriers, and possibly tailored chemotherapeutic treatment of patients, our finding has implications for broader BRCA genetic testing for patients with pancreatic ductal adenocarcinoma.
Asunto(s)
Proteína BRCA1/genética , Proteína BRCA2/genética , Carcinoma Ductal Pancreático/genética , Mutación de Línea Germinal , Neoplasias Pancreáticas/genética , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma Ductal Pancreático/etnología , Carcinoma Ductal Pancreático/patología , Análisis Mutacional de ADN/métodos , Femenino , Frecuencia de los Genes , Predisposición Genética a la Enfermedad , Herencia , Humanos , Incidencia , Judíos/genética , Masculino , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa Multiplex , Ontario/epidemiología , Neoplasias Pancreáticas/etnología , Neoplasias Pancreáticas/patología , Linaje , Fenotipo , Pronóstico , Estudios Prospectivos , Factores de RiesgoRESUMEN
BACKGROUND: Previous studies have reported additional cancers associated with BRCA mutations; however, the type, magnitude of risk, and sex differences remain to be clarified. The purpose of this study was to evaluate the incidence of cancers other than breast and ovarian cancer in known mutation carriers. METHODS: An institutional review board-approved study identified 1072 patients who had genetic counseling at the authors' institution and tested positive for a deleterious BRCA mutation. The expected number of cancer cases was calculated from the number of individuals in the study sample multiplied by the cancer incidence rates for the general population. The expected and observed numbers of cases were calculated in 5-year intervals to accommodate different age-related incidence rates. Standardized incidence ratios (SIRs) for each cancer type were calculated. RESULTS: Among the 1072 mutation carriers, 1177 cancers of 30 different cancer types were identified. Individuals with a BRCA1 mutation did not have a significant increase in cancers other than breast and ovarian cancer; however, a trend in melanoma was observed. Individuals with a BRCA2 mutation had significantly higher numbers of observed cases versus expected cases for pancreatic cancer in both men and women (SIR, 21.7; 95% confidence interval [CI], 13.1-34.0; P < .001) and for prostate cancer in men (SIR, 4.9; 95% CI, 2.0-10.1; P = .002). CONCLUSIONS: The results of this study uphold the current recommendations for hereditary breast and ovarian cancer screening of cancers other than breast and ovarian cancer by the National Comprehensive Cancer Network. Larger cohorts and collaborations are needed to further verify these findings.
Asunto(s)
Proteína BRCA1/genética , Proteína BRCA2/genética , Heterocigoto , Mutación , Neoplasias Pancreáticas/epidemiología , Neoplasias Pancreáticas/genética , Adulto , Anciano , Neoplasias de la Mama/genética , Femenino , Predisposición Genética a la Enfermedad , Pruebas Genéticas , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Neoplasias Ováricas/genética , Neoplasias Pancreáticas/etnología , Medición de Riesgo , Factores de Riesgo , Estados Unidos/epidemiologíaRESUMEN
Low vitamin D status is common globally and is associated with multiple disease outcomes. Understanding the correlates of vitamin D status will help guide clinical practice, research, and interpretation of studies. Correlates of circulating 25-hydroxyvitamin D (25(OH)D) concentrations measured in a single laboratory were examined in 4,723 cancer-free men and women from 10 cohorts participating in the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers, which covers a worldwide geographic area. Demographic and lifestyle characteristics were examined in relation to 25(OH)D using stepwise linear regression and polytomous logistic regression. The prevalence of 25(OH)D concentrations less than 25 nmol/L ranged from 3% to 36% across cohorts, and the prevalence of 25(OH)D concentrations less than 50 nmol/L ranged from 29% to 82%. Seasonal differences in circulating 25(OH)D were most marked among whites from northern latitudes. Statistically significant positive correlates of 25(OH)D included male sex, summer blood draw, vigorous physical activity, vitamin D intake, fish intake, multivitamin use, and calcium supplement use. Significant inverse correlates were body mass index, winter and spring blood draw, history of diabetes, sedentary behavior, smoking, and black race/ethnicity. Correlates varied somewhat within season, race/ethnicity, and sex. These findings help identify persons at risk for low vitamin D status for both clinical and research purposes.
Asunto(s)
Neoplasias/prevención & control , Deficiencia de Vitamina D/complicaciones , Deficiencia de Vitamina D/epidemiología , Vitamina D/sangre , Vitamina D/uso terapéutico , Adulto , Análisis de Varianza , Estudios de Casos y Controles , China/epidemiología , Estudios de Cohortes , Neoplasias Endometriales/epidemiología , Neoplasias Endometriales/etnología , Neoplasias Endometriales/prevención & control , Neoplasias Esofágicas/epidemiología , Neoplasias Esofágicas/etnología , Neoplasias Esofágicas/prevención & control , Femenino , Finlandia/epidemiología , Humanos , Neoplasias Renales/epidemiología , Neoplasias Renales/etnología , Neoplasias Renales/prevención & control , Modelos Logísticos , Linfoma no Hodgkin/epidemiología , Linfoma no Hodgkin/etnología , Linfoma no Hodgkin/prevención & control , Masculino , Neoplasias/etnología , Neoplasias Ováricas/epidemiología , Neoplasias Ováricas/etnología , Neoplasias Ováricas/prevención & control , Neoplasias Pancreáticas/epidemiología , Neoplasias Pancreáticas/etnología , Neoplasias Pancreáticas/prevención & control , Estudios Prospectivos , Factores de Riesgo , Neoplasias Gástricas/epidemiología , Neoplasias Gástricas/etnología , Neoplasias Gástricas/prevención & control , Estados Unidos/epidemiología , Deficiencia de Vitamina D/etnología , Deficiencia de Vitamina D/prevención & controlRESUMEN
Chaplains serving in the health care context provide a ministry to dying patients of inestimable worth as they comfort patients in the last chapter of the journey by being present, listening, and caring. Chaplains also play another important role, helping patients clarify ways in which their beliefs and values might influence health care decisions. This paper reviewed the current trends of spiritual diversity alongside the aging of a large Baby Boomer cohort. Chaplains may be challenged as they participate in the decision-making process, or as they support familes who make decisions about the care of loved ones nearing the end of life. Many of those who seek health care and comfort as the end of life approaches will bring a startling diversity of nonbelief, beliefs, and diverse religious and spiritual practices. This pattern of diversity will profoundly affect patients' decision-making around end-of-life issues. Case studies are used to illustrate possibilities for the chaplain's role at the bedside in the face of such diversity. The dimensional information of a new scale is presented for chaplains to assess diverse afterlife beliefs. As chaplains renew their studies of the worlds living religions, they will be better equipped to serve the needs of this large and spiritually diverse population.
Asunto(s)
Servicio de Capellanía en Hospital/organización & administración , Diversidad Cultural , Religión , Anciano , Arritmias Cardíacas/etnología , Arritmias Cardíacas/terapia , Actitud Frente a la Muerte/etnología , Budismo/psicología , Catolicismo/psicología , Femenino , Humanos , Indígenas Norteamericanos/etnología , Indígenas Norteamericanos/psicología , Masculino , Persona de Mediana Edad , Neoplasias Pancreáticas/etnología , Espiritualidad , Suicidio Asistido/etnología , Negativa del Paciente al Tratamiento/etnología , Estados UnidosRESUMEN
BACKGROUND: In the Multiethnic Cohort (MEC) study, we showed inverse associations between flavonols and pancreatic cancer risk. OBJECTIVE: We aimed to define a food pattern associated with intakes of quercetin, kaempferol, and myricetin; to examine the association of that pattern with pancreatic cancer risk; and to investigate the associations in an independent study. DESIGN: Reduced rank regression was applied to dietary data for 183,513 participants in the MEC. A food group pattern was extracted and simplified and applied to dietary data of 424,978 participants in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Dietary intake in both studies was assessed by using specially developed questionnaires. Multivariate Cox proportional hazards models were used to estimate relative risks for pancreatic cancer in the MEC (610 cases) and the EPIC (517 cases) studies. RESULTS: The food group pattern consisted mainly of tea, fruit, cabbage, and wine. In the MEC, inverse associations with pancreatic cancer in smokers were observed for the food group pattern [relative risk: 0.59 (95% CI: 0.31, 1.12) when extreme quintiles were compared; P for trend = 0.03]. In the EPIC study, the simplified pattern was not associated with pancreatic cancer risk (P for trend = 0.78). CONCLUSIONS: A food pattern associated with the intake of quercetin, kaempferol, and myricetin was associated with lower pancreatic cancer risk in smokers in a US-based population. However, failure to replicate the associations in an independent study weakens the conclusions and raises questions about the utility of food patterns for flavonols across populations.
Asunto(s)
Etnicidad/estadística & datos numéricos , Conducta Alimentaria , Flavonoles/administración & dosificación , Neoplasias Pancreáticas/epidemiología , Fumar/efectos adversos , Brassica/química , Estudios de Casos y Controles , Estudios de Cohortes , Intervalos de Confianza , Encuestas sobre Dietas , Conducta Alimentaria/etnología , Femenino , Flavonoides/administración & dosificación , Flavonoides/metabolismo , Flavonoles/metabolismo , Estudios de Seguimiento , Frutas/química , Humanos , Incidencia , Quempferoles/administración & dosificación , Quempferoles/metabolismo , Masculino , Análisis Multivariante , Neoplasias Pancreáticas/etnología , Neoplasias Pancreáticas/etiología , Neoplasias Pancreáticas/prevención & control , Valor Predictivo de las Pruebas , Modelos de Riesgos Proporcionales , Quercetina/administración & dosificación , Quercetina/metabolismo , Riesgo , Factores de Riesgo , Encuestas y Cuestionarios , Té/química , Vino/análisisRESUMEN
BACKGROUND: The relationship between diet and pancreatic cancer remains unclear. In this study, we assessed the role of diet and nutrition as risk factors for pancreatic cancer, using data obtained from direct interviews only, rather than data from less reliable interviews with next of kin. We evaluated whether dietary factors could explain the higher incidence of pancreatic cancer experienced by black Americans compared with white Americans. METHODS: We conducted a population-based case-control study of pancreatic cancer diagnosed in Atlanta (GA), Detroit (MI), and 10 New Jersey counties from August 1986 through April 1989. Reliable dietary histories were obtained for 436 patients and 2003 general-population control subjects aged 30-79 years. RESULTS: Obesity was associated with a statistically significant 50%-60% increased risk of pancreatic cancer that was consistent by sex and race. Although the magnitude of risk associated with obesity was identical in blacks and whites, a higher percentage of blacks were obese than were whites (women: 38% versus 16%; men: 27% versus 22%). A statistically significant positive trend in risk was observed with increasing caloric intake, with subjects in the highest quartile of caloric intake experiencing a 70% higher risk than those in the lowest quartile. A statistically significant interaction between body mass index (weight in kg/height in m2 for men and weight in kg/height in m1.5 for women) and total caloric intake was observed that was consistent by sex and race. Subjects in the highest quartile of both body mass index and caloric intake had a statistically significant 180% higher risk than those in the lowest quartile. CONCLUSIONS: Obesity is a risk factor for pancreatic cancer and appears to contribute to the higher risk of this disease among blacks than among whites in the United States, particularly among women. Furthermore, the interaction between body mass index and caloric intake suggests the importance of energy balance in pancreatic carcinogenesis.
Asunto(s)
Negro o Afroamericano/estadística & datos numéricos , Dieta/efectos adversos , Alimentos/efectos adversos , Fenómenos Fisiológicos de la Nutrición , Neoplasias Pancreáticas/etnología , Neoplasias Pancreáticas/etiología , Población Blanca/estadística & datos numéricos , Adulto , Anciano , Índice de Masa Corporal , Estudios de Casos y Controles , Café , Grasas de la Dieta , Ingestión de Energía , Femenino , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Oportunidad Relativa , Estados Unidos/epidemiologíaRESUMEN
To examine the relation between diet and pancreatic cancer, we conducted a population-based case-control study in western Washington. Cases (n = 148) were married men, aged 20-74 years, who were diagnosed with pancreatic cancer from July 1982 to June 1986. Controls (n = 188), identified by random digit dialing, were frequency matched to the cases by 5-year age groups. Wives responded as surrogates for both cases and controls. Wives were interviewed by telephone, and they completed a mailed, self-administered food frequency questionnaire. Results indicated that pancreatic cancer risk increased with increasing protein intake. The increased risk for heavy consumers of protein was largely confined to individuals aged 65 years and above. In that group, the odds ratio for those in the highest quartile of protein intake, relative to the lowest, was 6.0 (95% confidence interval 1.7-20.6). No association was found between pancreatic cancer risk and the intake of total fat, saturated fat, cholesterol, omega-3 fatty acids, or vitamins A and C. There was an unexpected inverse association between calcium intake and pancreatic cancer risk in these data. These findings are discussed in relation to possible etiologic mechanisms that they suggest.